Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Mintzer

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Epilepsia|August 26, 2009
Should enzyme-inducing antiepileptic drugs be considered first-line agents?Scott Mintzer, Richard T Mattson
Current Treatment Options in Neurology|September 16, 2010
Antiepileptic drugs and markers of vascular riskCarla Lopinto-Khoury, Scott Mintzer
Epilepsy & Behavior : E&B|March 25, 2008
When should a resection sparing mesial structures be considered for temporal lobe epilepsy?Scott Mintzer, Michael R Sperling
Epilepsy & Behavior : E&B|April 17, 2014
Use of antiepileptic drugs and lipid-lowering agents in the United StatesScott Mintzer, Vittorio Maio, Kathleen Foley
Seizure|December 28, 2013
Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsyKatharine Kenyon, Scott Mintzer, Maromi Nei
Epilepsy Research|November 30, 2021
Impact of carbamazepine on vitamin D levels: A meta-analysisCarla LoPinto-Khoury, Laura Brennan, Scott Mintzer
Epilepsy & Behavior : E&B|May 4, 2021
Reply to Scorza et alSamuel W Terman, James F Burke, Scott Mintzer
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|February 8, 2006
Predictive value of early EEG after epilepsy surgeryScott Mintzer, Wassim Nasreddine, Erasmo Passaro, et al.
Epilepsy & Behavior : E&B|June 5, 2012
B-vitamin deficiency in patients treated with antiepileptic drugsScott Mintzer, Christopher T Skidmore, Michael R Sperling
Epilepsia|March 15, 2006
Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepineScott Mintzer, Prashanthi Boppana, Jeanne Toguri, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Epilepsia|August 26, 2009
Should enzyme-inducing antiepileptic drugs be considered first-line agents?Scott Mintzer, Richard T Mattson
Current Treatment Options in Neurology|September 16, 2010
Antiepileptic drugs and markers of vascular riskCarla Lopinto-Khoury, Scott Mintzer
Epilepsy & Behavior : E&B|March 25, 2008
When should a resection sparing mesial structures be considered for temporal lobe epilepsy?Scott Mintzer, Michael R Sperling
Epilepsy & Behavior : E&B|April 17, 2014
Use of antiepileptic drugs and lipid-lowering agents in the United StatesScott Mintzer, Vittorio Maio, Kathleen Foley
Seizure|December 28, 2013
Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsyKatharine Kenyon, Scott Mintzer, Maromi Nei
Epilepsy Research|November 30, 2021
Impact of carbamazepine on vitamin D levels: A meta-analysisCarla LoPinto-Khoury, Laura Brennan, Scott Mintzer
Epilepsy & Behavior : E&B|May 4, 2021
Reply to Scorza et alSamuel W Terman, James F Burke, Scott Mintzer
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|February 8, 2006
Predictive value of early EEG after epilepsy surgeryScott Mintzer, Wassim Nasreddine, Erasmo Passaro, et al.
Epilepsy & Behavior : E&B|June 5, 2012
B-vitamin deficiency in patients treated with antiepileptic drugsScott Mintzer, Christopher T Skidmore, Michael R Sperling
Epilepsia|March 15, 2006
Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepineScott Mintzer, Prashanthi Boppana, Jeanne Toguri, et al.
Pageof 7